Publications
5491 Results
- Journal / Conference
- JCO Vol 40 Issue 6 Supp; ASCO Genitourinary (GU) Cancers Symposium 2022 (Feb 17-19, 2022, San Francisco, CA), poster
- Year
- 2022
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S2011
Randomized Phase II Trial Of Gemcitabine, Avelumab and Carboplatin vs. No Neoadjuvant Therapy Preceding Surgery for Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma (MIUC): SWOG Gap Trial (S2011)
- Journal / Conference
- Journal of Clinical Oncology Oct 1;40(28):3301-3309
- Year
- 2022
- Research Committee(s)
- Genitourinary
- PMID
- PMID35446628
- PMC
- PMC9553390
- Study Number(s)
- S1216
Orteronel for metastatic hormone sensitive prostate cancer: A multicenter, randomized, open-label phase III trial (SWOG-1216)
- Journal / Conference
- Society for Clinical Trials (MAY 15-18, 2022 San Diego, CA), poster
- Year
- 2022
- Research Committee(s)
- Multiple sites
A More Efficient Approach to Clinical Trial Data Collection: The SWOG-nCartes Pilot Collaboration
- Journal / Conference
- Society for Clinical Trials (MAY 15-18, 2022 San Diego, CA), poster
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery and Prevention and Epidemiology
- Study Number(s)
- S1415CD, S1904, S2108CD
Lessons from Implementing Practice-Level Cluster Randomized Studies within the NCORP Setting
- Journal / Conference
- Society for Clinical Trials (MAY 15-18, 2022 San Diego, CA), poster
- Year
- 2022
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S2114
A non-factorial analysis of a factorial Phase II trial design to evaluate single agent and combination consolidation therapies following CD19 CAR T-cell therapy for relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL): SWOG-S2114
- Journal / Conference
- Clinical Lung Cancer Jul;23(5):e317-e320
- Year
- 2022
- Research Committee(s)
- Lung
- PMID
- PMID35613998
- PMC
- PMC9634857
- Study Number(s)
- A082002
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
- Journal / Conference
- Clinical Cancer Research Sep 1;28(17):3752-3760
- Year
- 2022
- Research Committee(s)
- Lung
- PMID
- PMID35713632
- PMC
- PMC9444942
- Study Number(s)
- S1403
Circulating tumor DNA (ctDNA) kinetics predict progression-free and overall survival in EGFR TKI-treated patients with EGFR-mutant NSCLC (SWOG S1403)
- Journal / Conference
- Journal of Clinical Oncology Jul;23(5):e317-e320
- Year
- 2022
- Research Committee(s)
- Lung
- PMID
- PMID35658027
- Study Number(s)
- S1400, S1800A
Lung-MAP: A Collaborative Roadmap to Improve Cancer Outcomes [Editorial]
- Journal / Conference
- JAMA May 24;327(20):1963-1973
- Year
- 2022
- Research Committee(s)
- Breast
- PMID
- PMID35608580
- PMC
- PMC9131745
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial
- Journal / Conference
- JCO Oncology Practice May 20;40(15):1696-1698
- Year
- 2022
- Research Committee(s)
- Breast
- PMID
- PMID35417251